OPEN ACCESS | PEER-REVIEWED | RESEARCH ARTICLE | DOWNLOAD PDF | VIEW FULL-TEXT PDF | TOTAL VIEWS
Inductively coupled plasma with mass-spectrometry method development and validation for gadolinium in gadolinium-based contrast agents of pharmaceutical formulations
Subramanya Srinivas Kona (1) , Mallesh Changali (2) , Mahesh Kalva (3) , Narasimha Swamy Lakka (4,*)
(1) Department of Analytical Research and Development, Jodas Expoim Private Limited, Hyderabad, 502279, India
(2) Department of Analytical Research and Development, Jodas Expoim Private Limited, Hyderabad, 502279, India
(3) Department of Analytical Research and Development, Jodas Expoim Private Limited, Hyderabad, 502279, India
(4) Department of Analytical Research and Development, Jodas Expoim Private Limited, Hyderabad, 502279, India
(*) Corresponding Author
Received: 16 Feb 2020 | Revised: 22 Mar 2020 | Accepted: 25 Mar 2020 | Published: 30 Jun 2020 | Issue Date: June 2020
Gadolinium-based contrast agent interacts with the human body temporarily and improves the pictures of inside of the body produced by magnetic resonance imaging, computed tomography, X-rays and ultrasound and it also helps to distinguish the normal from abnormal conditions. In this study, the authors developed a simple, rapid, reliable and robust inductively coupled plasma mass-spectrometry method for estimation of gadolinium in gadolinium-based contrast agents to check the drug quality and ensure the patient safety. The samples were digested at 160°C using the microwave digestion system and the gadolinium was extracted in 0.4% (w/w) nitric acid. Interference of deposited gadolinium on sample cone and skimmer cone were investigated and evaluated. The developed method was validated as per ICH Q2 (R1) guideline and USP<730>. The precision was evaluated with six independent assays of gadolinium in each gadolinium-based contrast agent. The test method was found linear (r2 > 0.999) with five different levels covered from 25~200%, and accurate, mean recoveries were 92.5~107.5% at three different levels covered from 50~150%. The robustness was performed by changing the nitric acid concentration (0.4±0.04%, w/w) in diluent system. This method is suitable to quantitatively determine the amount of gadolinium in gadolinium-based contrast agent of drug products in presence of excipients used in formulation and also in drug substance.
Our editors have decided to support scientists to publish their manuscripts in European Journal of Chemistry without any financial constraints.
1- The article processing fee will not be charged from the articles containing the single-crystal structure characterization between July 1, 2022 and August 15, 2022 (Voucher code: SINGLE2022).
2. Young writers will not be charged for the article processing fee between July 1, 2022 and August 15, 2022 (Voucher code: YOUNG2022).
3. The article processing fee will not be charged from the articles containing a part of the PhD thesis between July 1, 2022 and August 15, 2022 (Voucher code: PhD2022).
European Journal of Chemistry
Links for Article
| | | | | | |
| | | | | | |
| | | |
Article MetricsThis Abstract was viewed 645 times | PDF Article downloaded 281 times
Jodas Expoim Private Limited, Hyderabad, 502279, India.
. Andrei R. Timerbaev
Application of ICP-MS to the development of metal-based drugs and diagnostic agents: where do we stand?
Journal of Analytical Atomic Spectrometry 36(2), 254, 2021
. Gadavist (gadobutrol) injection for intravenous use. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/201277s000lbl.pdf [accessed on May 5, 2019].
. Omniscan (gadodiamide) injection for intravenous use, https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020123s037lbl.pdf [accessed on May 5, 2019].
. Dotarem (gadoterate meglumine) injection for intravenous use. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204781s008lbl.pdf [accessed on May 5, 2019].
. Magnevist (gadopentetate dimeglumine) injection for intravenous use. https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019596s049lbl.pdf [accessed on April 24, 2019].
. Gadodiamide USP monograph, USP 41, 1900-1902, May 2018.
. Gadopentetate Dimeglumine Injection, USP 40, 4359-4360, December 2017.
. Gadobutrol Monohydrate, BP monograph, Ph. Eur. 9.3, 2018.
. David, C.; Stefanie, F.; Astrid, J.; Michael, S.; Philip, D.; Uwe, K. J. Trace Elem. Med. Biol. 2019, 51, 212-218.
. Eileen, M. S. F.; Egidius, E. U. Analyst 1998, 123, 675-679.
. Manrique, R. S.; Duran, G. M. E.; Gimenez, M. A. Pharm. World. Sci. 2008, 30(6), 1021-1022.
. Kuemmerer, K. J. Environ. Manage. 2009, 90(8), 2354-2366.
. U.S. Pharmacopeia, USP<730> Plasma Spectrochemistry, USP 41, 6482-6485, August 2018.
. Aldabe, J.; Santamaria, C.; Elustondo, D.; Lasherasa, E.; Santamaria, J. M. Anal. Methods 2013, 5(2), 554-559.
. U.S. Pharmacopeia, USP <233> Elemental Impurities-Procedures, USP 41, 6151-6155, August 2018.
. ICH Guideline, Q2 (R1) Validation of Analytical procedures (Text and Methodology), November 2005.
. Quantifying Uncertainty in Analytical Measurement. 3rd Ed, Eurachem, Olomouc, 2012.
. Agilent Technologies, Inc. Relative Isotopic Abundance Table, 2008.
How to cite
The other citation formats (EndNote | Reference Manager | ProCite | BibTeX | RefWorks) for this article can be found online at: How to cite item
DOI Link: https://doi.org/10.5155/eurjchem.11.2.133-138.1972
| | | | | | | | |
| | | | | | |
Save to Zotero Save to Mendeley
European Journal of Chemistry 2020, 11(2), 133-138 | doi: https://doi.org/10.5155/eurjchem.11.2.133-138.1972 | Get rights and content
- There are currently no refbacks.
Copyright (c) 2020 Authors
This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at http://www.eurjchem.com/index.php/eurjchem/pages/view/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (http://www.eurjchem.com/index.php/eurjchem/pages/view/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).
© Copyright 2010 - 2022 • Atlanta Publishing House LLC • All Right Reserved.
The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.
Copyright 2010-2022 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 2850 Smith Ridge Trce Peachtree Cor GA 30071-2636, USA. Registered in USA.